RE:Possible upcoming milestones?Their reducer is approved and on sale in some europeen countries, starting with Germany. That's their revenue source for the moment. It might be approved in some other countries in a near and mid term futur, good potential. Their 2nd product, TiaraII has more potential of revenu imo, It is on trial for FDA approval with something like 100 patient treated with very positive results. It's all in written in Q3 2017 MD&A, which everyone should read before investing.
They use to have 100 mil shares outstanding but to clear the 121 million$ dept to CardiaQ they had to do a PP which changes everything. When all warrants will be exerciced there will be 1,5B shares. From that you need to eveluate the value of the company. So 0,10$ makes it 150mil MKTCap. the thing is, if you're not in the know of the company, you can't predict what market would be fair value. I doubt they can even know, all depends on approvals and if insurance would cover medical fees for the device on patients. We only know that around 4 millions people in the USA are in need of that device that would prevent them from dying or have a really crappy life.
MD&A also talk about possible reverse split. That would be crucial to meet Nasdaq requirement and probably also TSX. So my call is there will be a RS soon enough. But it's not that important, what you gamble on is the TiaraII potential, that's about it. The CEO state that in mid and long term, TiaraII will be their most important revenu source, but how much is it worth??
Is it safe to drop some cash at this price? My call is YES. But do your DD and stay alert, this stock has shown in the past that it can moves really quick up and down.